Cytokinetics, Incorporated (CYTK)
USD 37.12
(-8.39%)
USD 37.12
(-8.39%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 642.37 Million USD | -6.05% |
| 2022 | 683.76 Million USD | 334.78% |
| 2021 | 157.26 Million USD | 181.06% |
| 2020 | 55.95 Million USD | -43.84% |
| 2019 | 99.63 Million USD | 63361.78% |
| 2018 | 157 Thousand USD | 100.17% |
| 2017 | -93.42 Million USD | -136.57% |
| 2016 | -39.49 Million USD | 21.7% |
| 2015 | -50.43 Million USD | -149.5% |
| 2014 | -20.21 Million USD | -0.28% |
| 2013 | -20.15 Million USD | -35.23% |
| 2012 | -14.9 Million USD | 20.83% |
| 2011 | -18.83 Million USD | -8.46% |
| 2010 | -17.36 Million USD | 29.35% |
| 2009 | -24.57 Million USD | 33.9% |
| 2008 | -37.17 Million USD | 65.54% |
| 2007 | -107.87 Million USD | -277.82% |
| 2006 | -28.55 Million USD | -587.5% |
| 2005 | -4.15 Million USD | -61.72% |
| 2004 | -2.56 Million USD | -182.82% |
| 2003 | -908 Thousand USD | 86.83% |
| 2002 | -6.89 Million USD | -295.63% |
| 2001 | 3.52 Million USD | 226.69% |
| 2000 | 1.07 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 634.56 Million USD | -1.22% |
| 2024 Q2 | 599.65 Million USD | -5.5% |
| 2023 Q3 | 648.77 Million USD | -4.69% |
| 2023 Q4 | 642.37 Million USD | -0.99% |
| 2023 FY | 642.37 Million USD | -6.05% |
| 2023 Q1 | 648.61 Million USD | -5.14% |
| 2023 Q2 | 680.67 Million USD | 4.94% |
| 2022 Q3 | 632.75 Million USD | 174.61% |
| 2022 Q2 | 230.42 Million USD | 11.44% |
| 2022 Q1 | 206.76 Million USD | 31.48% |
| 2022 FY | 683.76 Million USD | 334.78% |
| 2022 Q4 | 683.76 Million USD | 8.06% |
| 2021 Q3 | 175.77 Million USD | -17.69% |
| 2021 FY | 157.26 Million USD | 181.06% |
| 2021 Q1 | 183.72 Million USD | 228.35% |
| 2021 Q2 | 213.54 Million USD | 16.23% |
| 2021 Q4 | 157.26 Million USD | -10.53% |
| 2020 Q1 | 87.82 Million USD | -11.86% |
| 2020 FY | 55.95 Million USD | -43.84% |
| 2020 Q4 | 55.95 Million USD | 192.74% |
| 2020 Q3 | -60.33 Million USD | -178.45% |
| 2020 Q2 | 76.9 Million USD | -12.43% |
| 2019 Q1 | 12.95 Million USD | 8152.23% |
| 2019 Q3 | 12.96 Million USD | -31.58% |
| 2019 Q4 | 99.63 Million USD | 668.67% |
| 2019 FY | 99.63 Million USD | 63361.78% |
| 2019 Q2 | 18.94 Million USD | 46.22% |
| 2018 FY | 157 Thousand USD | 100.17% |
| 2018 Q1 | -83.05 Million USD | 11.1% |
| 2018 Q3 | 14.28 Million USD | 197.88% |
| 2018 Q2 | -14.59 Million USD | 82.43% |
| 2018 Q4 | 157 Thousand USD | -98.9% |
| 2017 Q4 | -93.42 Million USD | 2.52% |
| 2017 FY | -93.42 Million USD | -136.57% |
| 2017 Q1 | -24.16 Million USD | 38.8% |
| 2017 Q2 | -77.86 Million USD | -222.18% |
| 2017 Q3 | -95.84 Million USD | -23.09% |
| 2016 Q1 | -12.8 Million USD | 74.62% |
| 2016 FY | -39.49 Million USD | 21.7% |
| 2016 Q4 | -39.49 Million USD | -6977.6% |
| 2016 Q2 | 1.88 Million USD | 114.68% |
| 2016 Q3 | -558 Thousand USD | -129.68% |
| 2015 Q2 | -24.83 Million USD | -10.17% |
| 2015 Q3 | -25.96 Million USD | -4.52% |
| 2015 Q4 | -50.43 Million USD | -94.27% |
| 2015 FY | -50.43 Million USD | -149.5% |
| 2015 Q1 | -22.54 Million USD | -11.53% |
| 2014 Q3 | -12.9 Million USD | -4.47% |
| 2014 Q4 | -20.21 Million USD | -56.62% |
| 2014 FY | -20.21 Million USD | -0.28% |
| 2014 Q1 | -13.25 Million USD | 34.24% |
| 2014 Q2 | -12.35 Million USD | 6.8% |
| 2013 Q1 | -13.16 Million USD | 11.72% |
| 2013 Q3 | -19.25 Million USD | -12.9% |
| 2013 Q4 | -20.15 Million USD | -4.67% |
| 2013 FY | -20.15 Million USD | -35.23% |
| 2013 Q2 | -17.05 Million USD | -29.61% |
| 2012 Q2 | -63.65 Million USD | -257.31% |
| 2012 FY | -14.9 Million USD | 20.83% |
| 2012 Q4 | -14.9 Million USD | 3.14% |
| 2012 Q1 | -17.81 Million USD | 4.64% |
| 2012 Q3 | -15.39 Million USD | 75.82% |
| 2011 Q4 | -18.68 Million USD | -2.19% |
| 2011 FY | -18.83 Million USD | -8.46% |
| 2011 Q2 | -23.28 Million USD | -50.99% |
| 2011 Q1 | -15.41 Million USD | 6.72% |
| 2011 Q3 | -18.28 Million USD | 21.47% |
| 2010 Q1 | -19.99 Million USD | 12.93% |
| 2010 Q4 | -16.52 Million USD | 45.14% |
| 2010 FY | -17.36 Million USD | 29.35% |
| 2010 Q3 | -30.13 Million USD | -68.55% |
| 2010 Q2 | -17.87 Million USD | 10.58% |
| 2009 Q4 | -22.96 Million USD | -2.61% |
| 2009 FY | -24.57 Million USD | 33.9% |
| 2009 Q1 | -32.02 Million USD | 13.87% |
| 2009 Q3 | -22.37 Million USD | 67.66% |
| 2009 Q2 | -69.19 Million USD | -116.07% |
| 2008 Q2 | -80.25 Million USD | 18.01% |
| 2008 FY | -37.17 Million USD | 65.54% |
| 2008 Q1 | -97.88 Million USD | 9.26% |
| 2008 Q4 | -37.17 Million USD | 42.89% |
| 2008 Q3 | -65.09 Million USD | 18.89% |
| 2007 Q2 | -100.5 Million USD | -8.82% |
| 2007 Q3 | -98.77 Million USD | 1.71% |
| 2007 FY | -107.87 Million USD | -277.82% |
| 2007 Q1 | -92.35 Million USD | -223.46% |
| 2007 Q4 | -107.87 Million USD | -9.21% |
| 2006 Q3 | -38.24 Million USD | 5.9% |
| 2006 Q1 | -64.41 Million USD | -1451.05% |
| 2006 FY | -28.55 Million USD | -587.5% |
| 2006 Q4 | -28.55 Million USD | 25.34% |
| 2006 Q2 | -40.64 Million USD | 36.91% |
| 2005 Q2 | -1.59 Million USD | 67.5% |
| 2005 Q3 | -2.28 Million USD | -43.1% |
| 2005 Q4 | -4.15 Million USD | -82.07% |
| 2005 FY | -4.15 Million USD | -61.72% |
| 2005 Q1 | -4.9 Million USD | -91.0% |
| 2004 Q3 | -9.96 Million USD | -35.84% |
| 2004 Q4 | -2.56 Million USD | 74.22% |
| 2004 FY | -2.56 Million USD | -182.82% |
| 2004 Q2 | -7.33 Million USD | -1186.22% |
| 2004 Q1 | 675 Thousand USD | 174.34% |
| 2003 Q4 | -908 Thousand USD | 0.0% |
| 2003 FY | -908 Thousand USD | 86.83% |
| 2002 FY | -6.89 Million USD | -295.63% |
| 2001 FY | 3.52 Million USD | 226.69% |
| 2000 FY | 1.07 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 1248.323% |
| Alkermes plc | -166.73 Million USD | 485.256% |
| Agenus Inc. | 274.13 Million USD | -134.326% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 65.647% |
| Aptorum Group Limited | 1.35 Million USD | -47236.052% |
| Ardelyx, Inc. | 34.51 Million USD | -1761.3% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -14908.692% |
| Bicycle Therapeutics plc | -481.46 Million USD | 233.42% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -1676.324% |
| ChromaDex Corporation | -24.04 Million USD | 2771.208% |
| Chimerix, Inc. | -25.51 Million USD | 2617.428% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -9118.786% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 2813.063% |
| CRISPR Therapeutics AG | -150.84 Million USD | 525.849% |
| Precision BioSciences, Inc. | -85.41 Million USD | 852.104% |
| Dyadic International, Inc. | -6.37 Million USD | 10171.528% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 4131.708% |
| Fortress Biotech, Inc. | 7.66 Million USD | -8280.587% |
| Lantern Pharma Inc. | -21.7 Million USD | 3059.793% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 681.138% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 7619.124% |
| Incyte Corporation | -3.17 Billion USD | 120.232% |
| IO Biotech, Inc. | -140.69 Million USD | 556.558% |
| Jaguar Health, Inc. | 29.39 Million USD | -2085.608% |
| Novavax, Inc. | -298.29 Million USD | 315.349% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -11936.2% |
| Opthea Limited | 28.15 Million USD | -2181.358% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 3926.148% |
| ContextLogic Inc. | -232 Million USD | 376.884% |
| MiMedx Group, Inc. | -33.9 Million USD | 1994.847% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -6200.853% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 27823.976% |
| NextCure, Inc. | -6.47 Million USD | 10017.74% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 1371.999% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 10170.105% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -5181.246% |
| Vaxcyte, Inc. | -368.22 Million USD | 274.45% |
| PDS Biotechnology Corporation | -32.7 Million USD | 2063.906% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -3617.861% |
| Pharming Group N.V. | 109.8 Million USD | -485.017% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 3792.642% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 466.588% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3568.558% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 3568.558% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 9147.493% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 11061.98% |
| Acelyrin, Inc. | -216.9 Million USD | 396.156% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 11549.936% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 37360.557% |
| Summit Therapeutics Inc. | 34.67 Million USD | -1752.604% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 9542.481% |
| Senti Biosciences, Inc. | 1.74 Million USD | -36817.931% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 447.967% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 929.391% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 10696.701% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -643759.315% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -102188.535% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 648.82% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 481.835% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -479.392% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 8556.714% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 597.523% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -9217.033% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 365.045% |
| Immix Biopharma, Inc. | -17.5 Million USD | 3768.645% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 302.831% |
| MEI Pharma, Inc. | -3.7 Million USD | 17437.976% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -5034.458% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -297.158% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -2211.273% |
| Fortress Biotech, Inc. | 7.66 Million USD | -8280.587% |
| Precigen, Inc. | -481 Thousand USD | 133649.272% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -4461.977% |
| AlloVir, Inc. | -62.69 Million USD | 1124.647% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 1255.054% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -941.696% |
| ImmuCell Corporation | 10.99 Million USD | -5744.76% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 516.73% |
| Onconetix, Inc. | 5.33 Million USD | -11948.759% |
| PureTech Health plc | -167.19 Million USD | 484.201% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 2208.903% |
| Elevation Oncology, Inc. | -19.11 Million USD | 3460.038% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 13185.598% |
| Seer, Inc. | -4.24 Million USD | 15250.283% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 2772.43% |
| Innoviva, Inc. | 255.56 Million USD | -151.356% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 1249.885% |
| ESSA Pharma Inc. | -33.62 Million USD | 2010.594% |
| GlycoMimetics, Inc. | -40.98 Million USD | 1667.356% |
| GT Biopharma, Inc. | -1.02 Million USD | 63015.965% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 1047.689% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -948.651% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 579.1% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 4736.057% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 2324.896% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 852798.649% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 2181.433% |
| Aptose Biosciences Inc. | -8.19 Million USD | 7938.721% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 20629.508% |
| Soligenix, Inc. | -4.95 Million USD | 13073.027% |
| Century Therapeutics, Inc. | 847 Thousand USD | -75740.85% |
| Kura Oncology, Inc. | -20.11 Million USD | 3293.021% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 1669.594% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 7749.107% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -35162.324% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 20192.962% |
| Autolus Therapeutics plc | -186.59 Million USD | 444.253% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 1402.88% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 332.917% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -1774.554% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -290.813% |
| GRI Bio, Inc. | -1.79 Million USD | 35906.689% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 7250.937% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 2031.539% |
| IGM Biosciences, Inc. | -72.6 Million USD | 984.737% |
| INmune Bio, Inc. | -25.41 Million USD | 2627.929% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -325.55% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1368.031% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4053.211% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 22366.498% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -1589.786% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 1659.723% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -1914.653% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -69.962% |
| Verastem, Inc. | -37.27 Million USD | 1823.193% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 7180.04% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 1338.618% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 4344.281% |
| Histogen Inc. | -7.48 Million USD | 8679.832% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 3073.006% |
| Surrozen, Inc. | -32.66 Million USD | 2066.605% |
| Organovo Holdings, Inc. | -1.5 Million USD | 42725.879% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 15381.88% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -3288.001% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -24455.505% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -15356.497% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 7764.485% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 1578.689% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 4506.793% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 302.776% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 89063.798% |
| Apollomics, Inc. | -27.39 Million USD | 2444.851% |
| Amarin Corporation plc | -191.04 Million USD | 436.25% |
| Mesoblast Limited | 55.96 Million USD | -1047.851% |
| Turnstone Biologics Corp. | -14.58 Million USD | 4504.635% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 2639.823% |
| Synaptogenix, Inc. | -28.66 Million USD | 2341.237% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 68729.487% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -1218.173% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 74613.42% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 8940.695% |
| Exelixis, Inc. | -73.05 Million USD | 979.359% |
| Better Therapeutics, Inc. | -860 Thousand USD | 74794.419% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 2775.101% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 366.135% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -87170.978% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 8736.197% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -51125.837% |
| Gritstone bio, Inc. | 39.49 Million USD | -1526.67% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 863.81% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 24504.933% |
| Avid Bioservices, Inc. | 169.72 Million USD | -278.471% |
| Insmed Incorporated | 721.62 Million USD | 10.982% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 7126.978% |
| MediWound Ltd. | -5.32 Million USD | 12170.124% |
| OmniAb, Inc. | 9.2 Million USD | -6880.028% |
| Alector, Inc. | -35.63 Million USD | 1902.542% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -647.196% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 13135.146% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -4752.119% |
| Zai Lab Limited | -775 Million USD | 182.887% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -88.625% |
| Aura Biosciences, Inc. | -21.52 Million USD | 3084.307% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 878.822% |
| Immunic, Inc. | -45.34 Million USD | 1516.789% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 432.465% |
| Veracyte, Inc. | -203.82 Million USD | 415.16% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -0.639% |
| FibroGen, Inc. | 56.76 Million USD | -1031.594% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7113.61% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 22822.086% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 31127.248% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 86.006% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 19326.938% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 487.055% |
| TG Therapeutics, Inc. | 17.86 Million USD | -3496.305% |
| Galecto, Inc. | -21.21 Million USD | 3127.771% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 2800.744% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 59.069% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 2724.926% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 5682.445% |
| XBiotech Inc. | -200.02 Million USD | 421.149% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 863.81% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -14086.661% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 1921.66% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 931.894% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -11187.507% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 476.946% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 795.403% |
| Vaxxinity, Inc. | 10.13 Million USD | -6240.032% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 12.753% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 6065.813% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 1073.94% |
| NexImmune, Inc. | -3.13 Million USD | 20599.208% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 18705.063% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 4350.896% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 2470.376% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 7256.509% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 515750.813% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 1683.289% |
| Ainos, Inc. | 4.07 Million USD | -15652.412% |
| Pluri Inc. | 22.82 Million USD | -2713.842% |
| Prothena Corporation plc | -608.34 Million USD | 205.593% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 640.918% |
| Celularity Inc. | 65.19 Million USD | -885.384% |
| Rallybio Corporation | -24.1 Million USD | 2765.223% |
| Cue Biopharma, Inc. | -33.81 Million USD | 1999.441% |
| MeiraGTx Holdings plc | -40.3 Million USD | 1693.896% |
| Omeros Corporation | 331.17 Million USD | -93.967% |
| Humacyte, Inc. | -22.48 Million USD | 2956.764% |
| Immunocore Holdings plc | -358.59 Million USD | 279.136% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 2713.925% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 2178.807% |
| Blueprint Medicines Corporation | 702.83 Million USD | 8.603% |
| CalciMedica, Inc. | -5.53 Million USD | 11716.13% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 441.288% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 6389.133% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 1704.446% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 2031.772% |
| Pulmatrix, Inc. | -10.41 Million USD | 6266.574% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 10847.398% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 1784.159% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 676.625% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 1171.62% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 11131.633% |
| Nutriband Inc. | -251.65 Thousand USD | 255356.957% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 1982.74% |
| Vor Biopharma Inc. | 4.3 Million USD | -14838.884% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 110.642% |
| Evogene Ltd. | -19.63 Million USD | 3371.733% |
| ProKidney Corp. | -56.23 Million USD | 1242.279% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 1419.798% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 7054.195% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 52.902% |
| CorMedix Inc. | -43.05 Million USD | 1592.066% |
| BioLineRx Ltd. | 7.33 Million USD | -8656.434% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 2438.875% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -1292.012% |
| Atai Life Sciences N.V. | -28.55 Million USD | 2349.359% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -28699.088% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 2915.445% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -3522.058% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 955.652% |
| MediciNova, Inc. | -50.78 Million USD | 1364.922% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 915.141% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2855721.249% |
| GeoVax Labs, Inc. | -6.45 Million USD | 10055.26% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 421.474% |
| Biomea Fusion, Inc. | -166.57 Million USD | 485.647% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 458.917% |
| Mereo BioPharma Group plc | -51.46 Million USD | 1348.076% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 777.293% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 318.673% |
| Absci Corporation | -72.59 Million USD | 984.834% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13968.594% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 374.006% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 781.844% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 771.263% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 1744.03% |
| Allakos Inc. | -24.97 Million USD | 2672.06% |
| Imunon, Inc. | -4.21 Million USD | 15344.294% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 4457.428% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 574.425% |
| BioAtla, Inc. | -109.01 Million USD | 689.273% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -87170.978% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 68510.224% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -5268.31% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 3129.628% |
| XOMA Corporation | -29 Million USD | 2315.076% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 3979.058% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 7224.8% |
| aTyr Pharma, Inc. | -7.44 Million USD | 8723.6% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 615.398% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 408.589% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 885.497% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 792.487% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 74865.359% |
| Akari Therapeutics, Plc | -3.84 Million USD | 16806.684% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -39481.98% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 53.481% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 54165.573% |
| UroGen Pharma Ltd. | 4.39 Million USD | -14529.287% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -466.061% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -892554.457% |
| Orgenesis Inc. | 21.78 Million USD | -2848.825% |
| Entera Bio Ltd. | -10.62 Million USD | 6143.579% |
| GH Research PLC | -78.07 Million USD | 922.742% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 2982.143% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 2509.588% |
| Xencor, Inc. | 29.64 Million USD | -2066.955% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 32710.828% |
| Replimune Group, Inc. | 1.41 Million USD | -45393.768% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 262391.146% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 608.137% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 54165.573% |
| Portage Biotech Inc. | -4.98 Million USD | 12996.446% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 2855721.249% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 1071.495% |
| OncoCyte Corporation | -6.56 Million USD | 9887.78% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -71480.421% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 14200.578% |
| Purple Biotech Ltd. | -14.13 Million USD | 4643.585% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 2804.041% |
| scPharmaceuticals Inc. | -6.54 Million USD | 9914.698% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 3948.344% |
| HilleVax, Inc. | -165.48 Million USD | 488.175% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 25410.165% |
| Tharimmune, Inc. | -10.93 Million USD | 5974.269% |
| Genprex, Inc. | -6.73 Million USD | 9634.096% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 274.176% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 826.172% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 45950.964% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 19466.369% |
| OKYO Pharma Limited | -826.84 Thousand USD | 77789.249% |
| Savara Inc. | 153 Thousand USD | -419750.98% |
| Curis, Inc. | -23.88 Million USD | 2789.212% |
| Daré Bioscience, Inc. | -5.15 Million USD | 12554.112% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 82878.617% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 10447.487% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -54108.608% |
| BeiGene, Ltd. | -2.25 Billion USD | 128.511% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -5106.241% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 205.618% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 446.132% |
| Erasca, Inc. | -37.21 Million USD | 1826.064% |
| bluebird bio, Inc. | 108.57 Million USD | -491.661% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 49977.746% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -69.604% |
| DBV Technologies S.A. | -126.98 Million USD | 605.86% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 49977.746% |
| Moderna, Inc. | -2.9 Billion USD | 122.097% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 6305.294% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 6010.674% |
| Molecular Templates, Inc. | 707 Thousand USD | -90758.84% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 2147.662% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -85.331% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 882.789% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 800.286% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 2090.493% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 1968.664% |
| MacroGenics, Inc. | -66.98 Million USD | 1058.979% |
| RenovoRx, Inc. | -1.17 Million USD | 54863.171% |
| Adicet Bio, Inc. | -138.78 Million USD | 562.847% |
| Prime Medicine, Inc. | -27.94 Million USD | 2399.03% |
| Aditxt, Inc. | 18.12 Million USD | -3444.926% |
| Adagene Inc. | -87.62 Million USD | 833.072% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 15521.513% |
| Quantum-Si incorporated | -118.55 Million USD | 641.825% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -1684.119% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 8694.539% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 1424.233% |
| SciSparc Ltd. | -2.06 Million USD | 31207.603% |
| Vericel Corporation | 1.27 Million USD | -50203.211% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5456.805% |
| Minerva Neurosciences, Inc. | 41 Million USD | -1466.599% |
| Generation Bio Co. | 31.44 Million USD | -1942.648% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 466.308% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 2177.328% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -450.952% |
| Invivyd, Inc. | -198.47 Million USD | 423.652% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 811.612% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 26891.306% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 1007.433% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 9512.044% |
| 2seventy bio, Inc. | 181.71 Million USD | -253.505% |
| ADMA Biologics, Inc. | 90.06 Million USD | -613.224% |
| Clene Inc. | 3.34 Million USD | -19132.695% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 7172.476% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 3086.249% |
| GeoVax Labs, Inc. | -6.45 Million USD | 10055.26% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 286.669% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 2570.692% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -261.562% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 15799.902% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -12742.303% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 12431.964% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 592.979% |
| Evaxion Biotech A/S | 5.28 Million USD | -12050.387% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 670.652% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 589.341% |
| Trevena, Inc. | 2.25 Million USD | -28348.716% |
| Surrozen, Inc. | -32.66 Million USD | 2066.605% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 1347.082% |
| Cingulate Inc. | 3.08 Million USD | -20738.082% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 21971.706% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -8837.971% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 7013.748% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 909.818% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 588.674% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 708.641% |
| Clearmind Medicine Inc. | -3.94 Million USD | 16392.953% |
| Kronos Bio, Inc. | -36.05 Million USD | 1881.694% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -6727.208% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -43954.599% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 1283.965% |
| Statera Biopharma, Inc. | 14.41 Million USD | -4355.84% |
| ImmunityBio, Inc. | 618.22 Million USD | -3.906% |
| Korro Bio, Inc. | -132.94 Million USD | 583.194% |
| Kineta, Inc. | -4.54 Million USD | 14246.047% |
| BioVie Inc. | -17.73 Million USD | 3722.599% |
| Codexis, Inc. | -43.27 Million USD | 1584.532% |
| Celularity Inc. | 65.19 Million USD | -885.384% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 20370.495% |
| Celcuity Inc. | 6.78 Million USD | -9369.612% |
| Virax Biolabs Group Limited | -3.36 Million USD | 19190.125% |
| Cibus, Inc. | -8.07 Million USD | 8052.117% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 15289.69% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -13956.28% |
| IN8bio, Inc. | -16.38 Million USD | 4019.531% |
| Kodiak Sciences Inc. | -103.87 Million USD | 718.409% |
| Annexon, Inc. | -193.75 Million USD | 431.538% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -1784266.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 3770.907% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 18385.568% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 39.07% |
| Eyenovia, Inc. | 1.25 Million USD | -50934.478% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -2287.556% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19907.956% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 2032.12% |
| Arcellx, Inc. | -296.95 Million USD | 316.317% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 3393.202% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 1191.078% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 3199.204% |
| Moolec Science SA | 117.61 Thousand USD | -546060.386% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 1772.887% |
| Geron Corporation | 14.76 Million USD | -4251.819% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 1794.108% |
| Royalty Pharma plc | 5.65 Billion USD | 88.647% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 554.227% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 9290.629% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 12078.163% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 556.454% |
| Humacyte, Inc. | -22.48 Million USD | 2956.764% |
| Structure Therapeutics Inc. | -124.33 Million USD | 616.629% |
| 89bio, Inc. | -289.05 Million USD | 322.233% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 2644.854% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 36127.594% |
| Genelux Corporation | -6.89 Million USD | 9411.089% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 2168.231% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -668.397% |
| Notable Labs, Ltd. | -9.77 Million USD | 6670.908% |
| Liquidia Corporation | -80.17 Million USD | 901.202% |
| Mustang Bio, Inc. | -3.73 Million USD | 17294.111% |
| Immunovant, Inc. | -635.22 Million USD | 201.125% |
| Quantum-Si incorporated | -118.55 Million USD | 641.825% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 3757.322% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 15604.996% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -7902.641% |
| Acasti Pharma Inc. | -23 Million USD | 2892.315% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 19177.17% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 4053.211% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 566.366% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 20712.881% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 2989.403% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 3559.379% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 479.478% |
| PepGen Inc. | -60.67 Million USD | 1158.797% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 2895.839% |
| United Therapeutics Corporation | -507.7 Million USD | 226.526% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 3458.632% |
| Solid Biosciences Inc. | -47.75 Million USD | 1445.282% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 74613.42% |
| Immuneering Corporation | -54.94 Million USD | 1269.164% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 15381.88% |
| Silo Pharma, Inc. | -3.52 Million USD | 18326.897% |
| Belite Bio, Inc | -87.27 Million USD | 836.066% |
| XOMA Corporation | -29 Million USD | 2315.076% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 1008.627% |
| Bionomics Limited | 227 Million USD | -182.971% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 652.426% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 25460.126% |
| uniQure N.V. | -102.95 Million USD | 723.959% |
| Cassava Sciences, Inc. | -121.13 Million USD | 630.29% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 15521.513% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -1468.636% |
| Forte Biosciences, Inc. | -11.96 Million USD | 5470.554% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 20860.52% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -605911.321% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 19907.956% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -7113.61% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 8761.974% |
| Altimmune, Inc. | -134.48 Million USD | 577.646% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -224.324% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 25460.126% |
| Compugen Ltd. | -12.9 Million USD | 5078.084% |
| Peak Bio, Inc. | 10.34 Million USD | -6112.4% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 227086.572% |
| Benitec Biopharma Inc. | -50.58 Million USD | 1369.962% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 715.664% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -3169.901% |
| Zura Bio Limited | -99.8 Million USD | 743.621% |
| PolyPid Ltd. | 6.17 Million USD | -10311.216% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -766.665% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -3169.901% |
| Instil Bio, Inc. | 75.35 Million USD | -752.427% |
| argenx SE | -2.02 Billion USD | 131.662% |
| Immunome, Inc. | -97.02 Million USD | 762.041% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 2955.621% |
| Verona Pharma plc | -220.44 Million USD | 391.4% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 995.379% |
| Shattuck Labs, Inc. | -121.42 Million USD | 629.032% |
| CervoMed Inc. | -7.79 Million USD | 8343.099% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 446.294% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 14789.504% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 587.606% |
| Moolec Science SA | 117.61 Thousand USD | -546060.386% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 28175.982% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -3940.487% |
| AnaptysBio, Inc. | -18.15 Million USD | 3639.045% |
| Design Therapeutics, Inc. | -18.15 Million USD | 3639.24% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 1012.707% |
| NeurAxis, Inc. | 145.7 Thousand USD | -440786.754% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -5619.124% |
| Lumos Pharma, Inc. | -28.49 Million USD | 2354.491% |
| Achilles Therapeutics plc | -126.92 Million USD | 606.108% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 995.379% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 98062.881% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 3192.218% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -43954.599% |
| Nutriband Inc. | -251.65 Thousand USD | 255356.957% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 4977.17% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 8734.032% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -88.824% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -2606.434% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 243.556% |
| Palisade Bio, Inc. | -12.06 Million USD | 5425.143% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 557.82% |
| Beam Therapeutics Inc. | -262.72 Million USD | 344.506% |
| Neurogene Inc. | -131.95 Million USD | 586.811% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -2844.499% |
| AEON Biopharma, Inc. | -4.88 Million USD | 13263.361% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 270.304% |
| Sesen Bio, Inc. | -112.55 Million USD | 670.728% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 743.273% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 27460.674% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 1746.01% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 871.322% |
| Athira Pharma, Inc. | -88.99 Million USD | 821.774% |
| Vaccinex, Inc. | -1.28 Million USD | 49973.602% |
| HCW Biologics Inc. | 2.85 Million USD | -22386.694% |
| XOMA Corporation | -29 Million USD | 2315.076% |
| Nektar Therapeutics | 210.24 Million USD | -205.542% |
| Arvinas, Inc. | -313.8 Million USD | 304.707% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -39481.98% |
| Merus N.V. | -192.88 Million USD | 433.035% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -970.888% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 9358.749% |
| Rezolute, Inc. | -68.16 Million USD | 1042.337% |
| Clene Inc. | 3.34 Million USD | -19132.695% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 4971.252% |
| BeyondSpring Inc. | -13.75 Million USD | 4770.098% |
| Synlogic, Inc. | -6.68 Million USD | 9709.155% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -56546.561% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 7697.54% |
| Peak Bio, Inc. | 10.34 Million USD | -6112.4% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 879.388% |
| Krystal Biotech, Inc. | -350.23 Million USD | 283.412% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -417.52% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 480.111% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 20446.617% |
| MannKind Corporation | 143.89 Million USD | -346.405% |
| Ikena Oncology, Inc. | -109.15 Million USD | 688.49% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 8584.639% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 2040.701% |
| Gossamer Bio, Inc. | 180.35 Million USD | -256.171% |
| CohBar, Inc. | -5.93 Million USD | 10931.245% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 2259.379% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -13968.594% |
| Legend Biotech Corporation | -949.39 Million USD | 167.661% |
| Mural Oncology plc | -255.84 Million USD | 351.081% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -1894.015% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 13736.613% |
| Disc Medicine, Inc. | -358.28 Million USD | 279.293% |
| Champions Oncology, Inc. | 4.81 Million USD | -13249.377% |
| REGENXBIO Inc. | 54.76 Million USD | -1072.897% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 238982.588% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 525.344% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 7227.958% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 896.168% |
| Vaxart, Inc. | -8.24 Million USD | 7894.831% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 1380.136% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 605.146% |
| Cellectis S.A. | -43.85 Million USD | 1564.763% |
| Longeveron Inc. | -2.9 Million USD | 22189.821% |
| Repare Therapeutics Inc. | -107.85 Million USD | 695.572% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 33.665% |
| Inozyme Pharma, Inc. | 12 Million USD | -5251.316% |
| Revolution Medicines, Inc. | -608.2 Million USD | 205.618% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 52325.366% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 342.298% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 528.043% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 4205.4% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 86907.027% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 106.717% |
| Denali Therapeutics Inc. | -74.86 Million USD | 958.04% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 5456.805% |
| Veru Inc. | 4.77 Million USD | -13338.832% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 5812.004% |
| Cingulate Inc. | 3.08 Million USD | -20738.082% |
| Passage Bio, Inc. | 4.58 Million USD | -13910.294% |
| Context Therapeutics Inc. | -14.44 Million USD | 4545.534% |
| Exicure, Inc. | 5.84 Million USD | -10882.595% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 378.836% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 1723.381% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -3993.888% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 1192.079% |
| Nuvalent, Inc. | -335.38 Million USD | 291.532% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -36938.391% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 962.453% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 7325.782% |
| OmniAb, Inc. | 9.2 Million USD | -6880.028% |
| Anew Medical, Inc. | 1.43 Million USD | -44743.818% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -3821.265% |
| Lipocine Inc. | -4.75 Million USD | 13610.56% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 684.889% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -4117.53% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 1368.031% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -2480.636% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 9657.685% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 1075.849% |
| Ocugen, Inc. | -32.52 Million USD | 2075.253% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 850.654% |
| Q32 Bio Inc. | -37.94 Million USD | 1792.769% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 102388.535% |
| Alumis Inc. Common Stock | -13.52 Million USD | 4848.111% |
| Equillium, Inc. | -22.39 Million USD | 2968.757% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 2612.406% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 2068.85% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 259209.776% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -379.232% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -19986.679% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -195482.159% |
| Dominari Holdings Inc. | 195 Thousand USD | -329321.538% |
| Edesa Biotech, Inc. | -5.26 Million USD | 12296.373% |
| vTv Therapeutics Inc. | -8.91 Million USD | 7303.903% |
| Bio-Techne Corporation | 267.74 Million USD | -139.918% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 4063.058% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 643.95% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 7744.556% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 5177.638% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 362.065% |
| Nkarta, Inc. | 57.29 Million USD | -1021.088% |
| BioCardia, Inc. | 212 Thousand USD | -302905.66% |
| Iterum Therapeutics plc | 13.43 Million USD | -4680.265% |